Mitochondrial and microsomal derived reactive oxygen species mediate apoptosis induced by transforming growth factor-β1 in immortalized rat hepatocytes

被引:63
作者
Albright, CD
Salganik, RI
Craciunescu, CN
Mar, MH
Zeisel, SH
机构
[1] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA
关键词
apoptosis; cytochrome P4501A1; hepatocytes; mitochondria; reactive oxygen species; transforming growth factor-beta 1;
D O I
10.1002/jcb.10498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta1 (TGFbeta1) is a multifunctional cytokine that is over expressed during liver hepatocytes injury and regeneration. SV40-transformed CWSV-1 rat hepatocytes that are p53-defective undergo apoptosis in response to choline deficiency (CD) or TGFbeta1, which mediates CD-apoptosis. Reactive oxygen species (ROS) are essential mediators of apoptosis. We have shown that apoptosis induced by TGFbeta1 is accompanied by ROS generation and the ROS-trapping agent N-acetylcysteine (NAC) inhibits TGFbeta1-induced apoptosis. While persistent induction of ROS contributes to this form of apoptosis, the source of ROS generated downstream of TGFbeta1 is not clear. The mitochondria and the endoplasmic reticulum both harbor potent electron transfer chains that might be the source of ROS essential for completion of TGFbeta1-apoptosis. Here we show that CWSV-1 cells treated with cyclosporine A, which prevents opening of mitochondrial membrane pores required for ROS generation, inhibits TGFbeta1-induced apoptosis. A similar effect was obtained by treating these cells with rotenone, an inhibitor of complex 1 of the mitochondrial electron transfer chain. However, we demonstrate that TGFbeta1 induces cytochrome P450 1A1 and that metyrapone, a potent inhibitor of cytochrome P450 1A1, inhibits TGFbeta1-induced apoptosis. Therefore, our studies indicate that concurrent with promoting generation of ROS from mitochondria, TGFbeta1 also promotes generation of ROS from the cytochrome P450 electron transfer chain. Since inhibition of either of these two sources of ROS interferes with apoptosis, it is reasonable to conclude that the combined involvement of both pathways is essential for completion of TGFbeta1-induced apoptosis.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 42 条
[31]  
2-S
[32]   INTRACELLULAR HETEROGENEITY IN MITOCHONDRIAL-MEMBRANE POTENTIALS REVEALED BY A J-AGGREGATE-FORMING LIPOPHILIC CATION JC-1 [J].
SMILEY, ST ;
REERS, M ;
MOTTOLAHARTSHORN, C ;
LIN, M ;
CHEN, A ;
SMITH, TW ;
STEELE, GD ;
CHEN, LB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :3671-3675
[33]  
Tan K H, 1987, Free Radic Res Commun, V3, P273, DOI 10.3109/10715768709069793
[34]   Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1 [J].
Thannickal, VJ ;
Fanburg, BL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30334-30338
[35]   Altered mitochondrial function and overgeneration of reactive oxygen species precede the induction of apoptosis by 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine in p53-defective hepatocytes [J].
Vrablic, AS ;
Albright, CD ;
Craciunescu, CN ;
Salganik, RI ;
Zeisel, SH .
FASEB JOURNAL, 2001, 15 (10) :1739-1744
[36]  
WOODWORTH C, 1986, CANCER RES, V46, P4018
[37]   TUMORIGENICITY OF SIMIAN-VIRUS 40-HEPATOCYTE CELL-LINES - EFFECT OF INVITRO AND INVIVO PASSAGE ON EXPRESSION OF LIVER-SPECIFIC GENES AND ONCOGENES [J].
WOODWORTH, CD ;
KREIDER, JW ;
MENGEL, L ;
MILLER, T ;
MENG, YL ;
ISOM, HC .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (10) :4492-4501
[38]   GLUCOCORTICOID-INDUCED THYMOCYTE APOPTOSIS IS ASSOCIATED WITH ENDOGENOUS ENDONUCLEASE ACTIVATION [J].
WYLLIE, AH .
NATURE, 1980, 284 (5756) :555-556
[39]   Mitochondrial control of nuclear apoptosis [J].
Zamzami, N ;
Susin, SA ;
Marchetti, P ;
Hirsch, T ;
GomezMonterrey, I ;
Castedo, M ;
Kroemer, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1533-1544
[40]   REDUCTION IN MITOCHONDRIAL POTENTIAL CONSTITUTES AN EARLY IRREVERSIBLE STEP OF PROGRAMMED LYMPHOCYTE DEATH IN-VIVO [J].
ZAMZAMI, N ;
MARCHETTI, P ;
CASTEDO, M ;
ZANIN, C ;
VAYSSIERE, JL ;
PETIT, PX ;
KROEMER, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1661-1672